Paul T Quinlan sold $311K of Oruka Therapeutics, Inc. (ORKA) stock

Paul T Quinlan, General Counsel of Oruka Therapeutics, Inc. (ORKA), sold 10,000 shares of ORKA stock worth $311K, per an SEC Form 4 filed Sep 21, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Sep 21, 2026.

ORKA has moved +0.0% since the trade date, from $93.38 to $93.38 (Sep 21, 2026 close).